{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:35:56Z","timestamp":1790019356441,"version":"4.0.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"15","license":[{"start":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T00:00:00Z","timestamp":1624233600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T00:00:00Z","timestamp":1624233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008019","name":"\u00c5bo Akademi","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100008019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008019","name":"\u00c5bo Akademi","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100008019","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Finnish-Norwegian Medical Foundation","award":["001"],"award-info":[{"award-number":["001"]}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004155","name":"Magnus Ehrnroothin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100004155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010116","name":"Medicinska Underst\u00f6dsf\u00f6reningen Liv och H\u00e4lsa","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/100010116","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Abo Akademi University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Stromal interaction molecule 1 (STIM1) and the ORAI1 calcium channel mediate store-operated calcium entry (SOCE) and regulate a multitude of cellular functions. The identity and function of these proteins in thyroid cancer remain elusive. We show that STIM1 and ORAI1 expression is elevated in thyroid cancer cell lines, compared to primary thyroid cells. Knock-down of STIM1 or ORAI1 attenuated SOCE, reduced invasion, and the expression of promigratory sphingosine 1-phosphate and vascular endothelial growth factor-2 receptors in thyroid cancer ML-1 cells. Cell proliferation was attenuated in these knock-down cells due to increased G1 phase of the cell cycle and enhanced expression of cyclin-dependent kinase inhibitory proteins p21 and p27. STIM1 protein was upregulated in thyroid cancer tissue, compared to normal tissue. Downregulation of STIM1 restored expression of thyroid stimulating hormone receptor, thyroid specific proteins and increased iodine uptake. STIM1 knockdown ML-1 cells were more susceptible to chemotherapeutic drugs, and significantly reduced tumor growth in Zebrafish. Furthermore, STIM1-siRNA-loaded mesoporous polydopamine nanoparticles attenuated invasion and proliferation of ML-1 cells. Taken together, our data suggest that STIM1 is a potential diagnostic and therapeutic target for treatment of thyroid cancer.<\/jats:p>","DOI":"10.1007\/s00018-021-03880-0","type":"journal-article","created":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T12:04:49Z","timestamp":1624277089000},"page":"5827-5846","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Stromal interaction molecule 1 (STIM1) knock down attenuates invasion and proliferation and enhances the expression of thyroid-specific proteins in human follicular thyroid cancer cells"],"prefix":"10.1007","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1935-8462","authenticated-orcid":false,"given":"Muhammad Yasir","family":"Asghar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taru","family":"Lassila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilkka","family":"Paatero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Van Dien","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauliina","family":"Kronqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Slita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoffer","family":"L\u00f6f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Rosenholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kid","family":"T\u00f6rnquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,21]]},"reference":[{"key":"3880_CR1","doi-asserted-by":"publisher","first-page":"e2639","DOI":"10.1210\/clinem\/dgaa223","volume":"105","author":"R Vigneri","year":"2020","unstructured":"Vigneri R, Malandrino P, Russo M (2020) Is thyroid cancer increasing in incidence and aggressiveness? J Clin Endocrinol Metab 105:e2639\u2013e2640. https:\/\/doi.org\/10.1210\/clinem\/dgaa223","journal-title":"J Clin Endocrinol Metab"},{"key":"3880_CR2","doi-asserted-by":"publisher","first-page":"15077","DOI":"10.1038\/nrdp.2015.77","volume":"1","author":"H Dralle","year":"2015","unstructured":"Dralle H, Machens A, Basa J et al (2015) Follicular cell-derived thyroid cancer. Nat Rev Dis Prim 1:15077. https:\/\/doi.org\/10.1038\/nrdp.2015.77","journal-title":"Nat Rev Dis Prim"},{"key":"3880_CR3","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/B978-0-12-801238-3.96018-5","volume":"4","author":"R Elisei","year":"2018","unstructured":"Elisei R (2018) Thyroid carcinoma. Encycl Endocr Dis Elsevier 4:573\u2013585. https:\/\/doi.org\/10.1016\/B978-0-12-801238-3.96018-5","journal-title":"Encycl Endocr Dis Elsevier"},{"key":"3880_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/542358","volume":"2011","author":"G Nagaiah","year":"2011","unstructured":"Nagaiah G, Hossain A, Mooney CJ et al (2011) Anaplastic thyroid cancer: a review of epidemiology, pathogenesis, and treatment. J Oncol 2011:1\u201313. https:\/\/doi.org\/10.1155\/2011\/542358","journal-title":"J Oncol"},{"key":"3880_CR5","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1210\/jc.2002-021907","volume":"88","author":"MN Nikiforova","year":"2003","unstructured":"Nikiforova MN, Lynch R, Biddinger PW et al (2003) RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab 88:2318\u20132326. https:\/\/doi.org\/10.1210\/jc.2002-021907","journal-title":"J Clin Endocrinol Metab"},{"key":"3880_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1677\/ERC-08-0154","volume":"16","author":"RC Smallridge","year":"2009","unstructured":"Smallridge RC, Marlow LA, Copland JA (2009) Anaplastic thyroid cancer: Molecular pathogenesis and emerging therapies. Endocr Relat Cancer 16:17\u201344. https:\/\/doi.org\/10.1677\/ERC-08-0154","journal-title":"Endocr Relat Cancer"},{"key":"3880_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0143-4160(86)90026-6","volume":"7","author":"JW Putney","year":"1986","unstructured":"Putney JW (1986) A model for receptor-regulated calcium entry. Cell Calcium 7:1\u20132. https:\/\/doi.org\/10.1016\/0143-4160(86)90026-6","journal-title":"Cell Calcium"},{"key":"3880_CR8","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/j.bbamcr.2015.10.003","volume":"1863","author":"I Jardin","year":"2016","unstructured":"Jardin I, Rosado JA (2016) STIM and calcium channel complexes in cancer. Biochim Biophys Acta Mol Cell Res 1863:1418\u20131426. https:\/\/doi.org\/10.1016\/j.bbamcr.2015.10.003","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"3880_CR9","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.2741\/4641","volume":"23","author":"P Mo","year":"2018","unstructured":"Mo P, Yang S (2018) The store-operated calcium channels in cancer metastasis: from cell migration, invasion to metastatic colonization. Front Biosci Landmark 23:1241\u20131256. https:\/\/doi.org\/10.2741\/4641","journal-title":"Front Biosci Landmark"},{"key":"3880_CR10","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.bbamcr.2016.11.028","volume":"1864","author":"JW Putney","year":"2017","unstructured":"Putney JW, Steinckwich-Besan\u00e7on N, Numaga-Tomita T et al (2017) The functions of store-operated calcium channels. Biochim Biophys Acta Mol Cell Res 1864:900\u2013906. https:\/\/doi.org\/10.1016\/j.bbamcr.2016.11.028","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"3880_CR11","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1152\/ajpcell.00364.2015","volume":"310","author":"A Fiorio Pla","year":"2016","unstructured":"Fiorio Pla A, Kondratska K, Prevarskaya N (2016) STIM and ORAI proteins: crucial roles in hallmarks of cancer. Am J Physiol Cell Physiol 310:509\u2013519. https:\/\/doi.org\/10.1152\/ajpcell.00364.2015","journal-title":"Am J Physiol Cell Physiol"},{"key":"3880_CR12","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1083\/jcb.200502019","volume":"169","author":"J Roos","year":"2005","unstructured":"Roos J, DiGregorio PJ, Yeromin AV et al (2005) STIM1, an essential and conserved component of store-operated Ca 2+ channel function. J Cell Biol 169:435\u2013445. https:\/\/doi.org\/10.1083\/jcb.200502019","journal-title":"J Cell Biol"},{"key":"3880_CR13","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/ncb1590","volume":"9","author":"JP Yuan","year":"2007","unstructured":"Yuan JP, Zeng W, Huang GN et al (2007) STIM1 heteromultimerizes TRPC channels to determine their function as store-operated channels. Nat Cell Biol 9:636\u2013645. https:\/\/doi.org\/10.1038\/ncb1590","journal-title":"Nat Cell Biol"},{"key":"3880_CR14","doi-asserted-by":"publisher","first-page":"16116","DOI":"10.1074\/jbc.M115.643668","volume":"290","author":"MY Asghar","year":"2015","unstructured":"Asghar MY, Magnusson M, Kemppainen K et al (2015) Transient receptor potential canonical 1 (TRPC1) channels as regulators of sphingolipid and VEGF receptor expression: Implications for thyroid cancer cell migration and proliferation. J Biol Chem 290:16116\u201316131. https:\/\/doi.org\/10.1074\/jbc.M115.643668","journal-title":"J Biol Chem"},{"key":"3880_CR15","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ceca.2018.07.011","volume":"74","author":"SB Chalmers","year":"2018","unstructured":"Chalmers SB, Monteith GR (2018) ORAI channels and cancer. Cell Calcium 74:160\u2013167. https:\/\/doi.org\/10.1016\/j.ceca.2018.07.011","journal-title":"Cell Calcium"},{"key":"3880_CR16","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1042\/BJ20060299","volume":"398","author":"S Balthasar","year":"2006","unstructured":"Balthasar S, Samulin J, Ahlgren H et al (2006) Sphingosine 1-phosphate receptor expression profile and regulation of migration in human thyroid cancer cells. Biochem J 398:547\u2013556. https:\/\/doi.org\/10.1042\/BJ20060299","journal-title":"Biochem J"},{"key":"3880_CR17","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1210\/me.2012-1171","volume":"26","author":"C L\u00f6f","year":"2012","unstructured":"L\u00f6f C, Sukumaran P, Viitanen T et al (2012) Communication between the calcium and cAMP pathways regulate the expression of the TSH receptor: TRPC2 in the center of action. Mol Endocrinol 26:2046\u20132057. https:\/\/doi.org\/10.1210\/me.2012-1171","journal-title":"Mol Endocrinol"},{"key":"3880_CR18","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1530\/ERC-12-0092","volume":"19","author":"MY Asghar","year":"2012","unstructured":"Asghar MY, Viitanen T, Kemppainen K, T\u00f6rnquist K (2012) Sphingosine 1-phosphate and human ether-a\u2019-go-go-related gene potassium channels modulate migration in human anaplastic thyroid cancer cells. Endocr Relat Cancer 19:667\u2013680. https:\/\/doi.org\/10.1530\/ERC-12-0092","journal-title":"Endocr Relat Cancer"},{"key":"3880_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ab.2009.08.038","volume":"396","author":"F Waltz","year":"2010","unstructured":"Waltz F, Pillette L, Ambroise Y (2010) A nonradioactive iodide uptake assay for sodium iodide symporter function. Anal Biochem 396:91\u201395. https:\/\/doi.org\/10.1016\/j.ab.2009.08.038","journal-title":"Anal Biochem"},{"key":"3880_CR20","doi-asserted-by":"publisher","first-page":"12119","DOI":"10.1021\/acs.langmuir.6b03294","volume":"32","author":"F Chen","year":"2016","unstructured":"Chen F, Xing Y, Wang Z et al (2016) Nanoscale polydopamine (PDA) meets \u03c0\u2013\u03c0 interactions: an interface-directed coassembly approach for mesoporous nanoparticles. Langmuir 32:12119\u201312128. https:\/\/doi.org\/10.1021\/acs.langmuir.6b03294","journal-title":"Langmuir"},{"key":"3880_CR21","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.actbio.2019.01.002","volume":"86","author":"Z Wang","year":"2019","unstructured":"Wang Z, Wang L, Prabhakar N et al (2019) CaP coated mesoporous polydopamine nanoparticles with responsive membrane permeation ability for combined photothermal and siRNA therapy. Acta Biomater 86:416\u2013428. https:\/\/doi.org\/10.1016\/j.actbio.2019.01.002","journal-title":"Acta Biomater"},{"key":"3880_CR22","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.21769\/bioprotoc.3027","volume":"8","author":"I Paatero","year":"2018","unstructured":"Paatero I, Alve S, Gramolelli S et al (2018) Zebrafish embryo xenograft and metastasis assay. Bio Protocol 8:3027. https:\/\/doi.org\/10.21769\/bioprotoc.3027","journal-title":"Bio Protocol"},{"key":"3880_CR23","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.32490","volume":"7","author":"P Pekkonen","year":"2018","unstructured":"Pekkonen P, Alve S, Balistreri G et al (2018) Lymphatic endothelium stimulates melanoma metastasis and invasion via MMP14-dependent Notch3 and \u03b21-integrin activation. Elife 7:e32490. https:\/\/doi.org\/10.7554\/eLife.32490","journal-title":"Elife"},{"key":"3880_CR24","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.stem.2007.11.002","volume":"2","author":"RM White","year":"2008","unstructured":"White RM, Sessa A, Burke C et al (2008) Transparent adult zebrafish as a tool for in vivo transplantation analysis. Cell Stem Cell 2:183\u2013189. https:\/\/doi.org\/10.1016\/j.stem.2007.11.002","journal-title":"Cell Stem Cell"},{"key":"3880_CR25","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/oso\/9780199638086.001.0001","volume-title":"Zebrafish (Practical approach series)","author":"C Nusslein-Volhard","year":"2002","unstructured":"Nusslein-Volhard C, Dahm R (2002) Zebrafish (Practical approach series). OUP Oxford, New York, p 328"},{"key":"3880_CR26","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E et al (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9:676\u2013682. https:\/\/doi.org\/10.1038\/nmeth.2019","journal-title":"Nat Methods"},{"key":"3880_CR27","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15:550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8","journal-title":"Genome Biol"},{"key":"3880_CR28","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1152\/ajpcell.00364.2015","volume":"310","author":"A Fiorio Pla","year":"2016","unstructured":"Fiorio Pla A, Kondratska K, Prevarskaya N (2016) STIM and ORAI proteins: crucial roles in hallmarks of cancer. Am J Physiol Physiol 310:509\u2013519. https:\/\/doi.org\/10.1152\/ajpcell.00364.2015","journal-title":"Am J Physiol Physiol"},{"key":"3880_CR29","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nrc3105","volume":"11","author":"N Prevarskaya","year":"2011","unstructured":"Prevarskaya N, Skryma R, Shuba Y (2011) Calcium in tumour metastasis: new roles for known actors. Nat Rev Cancer 11:609\u2013618. https:\/\/doi.org\/10.1038\/nrc3105","journal-title":"Nat Rev Cancer"},{"key":"3880_CR30","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ccr.2008.12.019","volume":"15","author":"S Yang","year":"2009","unstructured":"Yang S, Zhang JJ, Huang XY (2009) Orai1 and STIM1 are critical for breast tumor cell migration and metastasis. Cancer Cell 15:124\u2013134. https:\/\/doi.org\/10.1016\/j.ccr.2008.12.019","journal-title":"Cancer Cell"},{"key":"3880_CR31","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1677\/ERC-07-0253","volume":"15","author":"S Balthasar","year":"2008","unstructured":"Balthasar S, Bergelin N, L\u00f6f C et al (2008) Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells. Endocr Relat Cancer 15:521\u2013534. https:\/\/doi.org\/10.1677\/ERC-07-0253","journal-title":"Endocr Relat Cancer"},{"key":"3880_CR32","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1152\/ajpcell.00064.2015","volume":"309","author":"A Vashisht","year":"2015","unstructured":"Vashisht A, Trebak M, Motiani RK (2015) STIM and orai proteins as novel targets for cancer therapy. A review in the theme: cell and molecular processes in cancer metastasis. Am J Physiol Cell Physiol 309:457\u2013469. https:\/\/doi.org\/10.1152\/ajpcell.00064.2015","journal-title":"Am J Physiol Cell Physiol"},{"key":"3880_CR33","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.mce.2015.01.037","volume":"404","author":"V Kalhori","year":"2015","unstructured":"Kalhori V, T\u00f6rnquist K (2015) MMP2 and MMP9 participate in S1P-induced invasion of follicular ML-1 thyroid cancer cells. Mol Cell Endocrinol 404:113\u2013122. https:\/\/doi.org\/10.1016\/j.mce.2015.01.037","journal-title":"Mol Cell Endocrinol"},{"key":"3880_CR34","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1210\/jc.84.9.3228","volume":"84","author":"V Lazar","year":"1999","unstructured":"Lazar V, Bidart JM, Caillou B et al (1999) Expression of the Na+\/I\u2212 symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes. J Clin Endocrinol Metab 84:3228\u20133234. https:\/\/doi.org\/10.1210\/jc.84.9.3228","journal-title":"J Clin Endocrinol Metab"},{"key":"3880_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkm1094","volume":"36","author":"H De Martimprey","year":"2008","unstructured":"De Martimprey H, Bertrand JR, Fusco A et al (2008) siRNA nanoformulation against the Ret\/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma. Nucleic Acids Res 36:e2. https:\/\/doi.org\/10.1093\/nar\/gkm1094","journal-title":"Nucleic Acids Res"},{"key":"3880_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpb.2019.12.015","volume":"148","author":"E Niemel\u00e4","year":"2020","unstructured":"Niemel\u00e4 E, Desai D, Niemi R et al (2020) Nanoparticles carrying fingolimod and methotrexate enables targeted induction of apoptosis and immobilization of invasive thyroid cancer. Eur J Pharm Biopharm 148:1\u20139. https:\/\/doi.org\/10.1016\/j.ejpb.2019.12.015","journal-title":"Eur J Pharm Biopharm"},{"key":"3880_CR37","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1186\/s12885-019-5947-z","volume":"19","author":"B Karacicek","year":"2019","unstructured":"Karacicek B, Erac Y, Tosun M (2019) Functional consequences of enhanced expression of STIM1 and Orai1 in Huh-7 hepatocellular carcinoma tumor-initiating cells. BMC Cancer 19:751. https:\/\/doi.org\/10.1186\/s12885-019-5947-z","journal-title":"BMC Cancer"},{"key":"3880_CR38","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00262-010-0968-0","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57\u201370. https:\/\/doi.org\/10.1007\/s00262-010-0968-0","journal-title":"Cell"},{"key":"3880_CR39","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"key":"3880_CR40","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.molmed.2010.01.005","volume":"16","author":"N Prevarskaya","year":"2010","unstructured":"Prevarskaya N, Skryma R, Shuba Y (2010) Ion channels and the hallmarks of cancer. Trends Mol Med 16:107\u2013121. https:\/\/doi.org\/10.1016\/j.molmed.2010.01.005","journal-title":"Trends Mol Med"},{"key":"3880_CR41","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1152\/physrev.00044.2016","volume":"98","author":"N Prevarskaya","year":"2018","unstructured":"Prevarskaya N, Skryma R, Shuba Y (2018) Ion channels in cancer: are cancer hallmarks oncochannelopathies? Physiol Rev 98:559\u2013621. https:\/\/doi.org\/10.1152\/physrev.00044.2016","journal-title":"Physiol Rev"},{"key":"3880_CR42","doi-asserted-by":"publisher","first-page":"4799","DOI":"10.18632\/oncotarget.2035","volume":"5","author":"S Schmidt","year":"2014","unstructured":"Schmidt S, Liu G, Liu G et al (2014) Enhanced Orai1 and STIM1 expression as well as store operated Ca2+ entry in therapy resistant ovary carcinoma cells. Oncotarget 5:4799\u20134810. https:\/\/doi.org\/10.18632\/oncotarget.2035","journal-title":"Oncotarget"},{"key":"3880_CR43","doi-asserted-by":"publisher","first-page":"15225","DOI":"10.1073\/pnas.1103315108","volume":"108","author":"YF Chen","year":"2011","unstructured":"Chen YF, Chiu WT, Chen YT et al (2011) Calcium store sensor stromal-interaction molecule 1-dependent signaling plays an important role in cervical cancer growth, migration, and angiogenesis. Proc Natl Acad Sci USA 108:15225\u201315230. https:\/\/doi.org\/10.1073\/pnas.1103315108","journal-title":"Proc Natl Acad Sci USA"},{"key":"3880_CR44","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1083\/jcb.201407082","volume":"207","author":"J Sun","year":"2014","unstructured":"Sun J, Lu F, He H et al (2014) STIM1- and Orai1-mediated Ca(2+) oscillation orchestrates invadopodium formation and melanoma invasion. J Cell Biol 207:535\u2013548. https:\/\/doi.org\/10.1083\/jcb.201407082","journal-title":"J Cell Biol"},{"key":"3880_CR45","doi-asserted-by":"publisher","first-page":"4358","DOI":"10.1038\/onc.2014.366","volume":"34","author":"JY Wang","year":"2015","unstructured":"Wang JY, Sun J, Huang MY et al (2015) STIM1 overexpression promotes colorectal cancer progression, cell motility and COX-2 expression. Oncogene 34:4358\u20134367. https:\/\/doi.org\/10.1038\/onc.2014.366","journal-title":"Oncogene"},{"key":"3880_CR46","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13046-015-0196-8","volume":"34","author":"S Zhao","year":"2015","unstructured":"Zhao S, Huang J, Ye J (2015) A fresh look at zebrafish from the perspective of cancer research. J Exp Clin Cancer Res 34:80. https:\/\/doi.org\/10.1186\/s13046-015-0196-8","journal-title":"J Exp Clin Cancer Res"},{"key":"3880_CR47","doi-asserted-by":"publisher","first-page":"935","DOI":"10.3390\/genes10110935","volume":"10","author":"M Hason","year":"2019","unstructured":"Hason M, Bart\u016fn\u0115k P (2019) Zebrafish models of cancer-new insights on modeling human cancer in a non-mammalian vertebrate. Genes (Basel) 10:935. https:\/\/doi.org\/10.3390\/genes10110935","journal-title":"Genes (Basel)"},{"key":"3880_CR48","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jbior.2017.09.006","volume":"68","author":"NJ Pyne","year":"2018","unstructured":"Pyne NJ, El Buri A, Adams DR, Pyne S (2018) Sphingosine 1-phosphate and cancer. Adv Biol Regul 68:97\u2013106. https:\/\/doi.org\/10.1016\/j.jbior.2017.09.006","journal-title":"Adv Biol Regul"},{"key":"3880_CR49","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1210\/\/en.2009-1387","volume":"151","author":"N Bergelin","year":"2010","unstructured":"Bergelin N, L\u00f6f C, Balthasar S et al (2010) S1P1 and VEGFR-2 form a signaling complex with extracellularly regulated kinase 1\/2 and protein kinase C-\u03b1 regulating ML-1 thyroid carcinoma cell migration. Endocrinology 151:2994\u20133005. https:\/\/doi.org\/10.1210\/\/en.2009-1387","journal-title":"Endocrinology"},{"key":"3880_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066189","volume":"8","author":"V Kalhori","year":"2013","unstructured":"Kalhori V, Kemppainen K, Asghar MY et al (2013) Sphingosine-1-phosphate as a regulator of hypoxia-induced factor-1\u03b1 in thyroid follicular carcinoma cells. PLoS ONE 8:e66189. https:\/\/doi.org\/10.1371\/journal.pone.0066189","journal-title":"PLoS ONE"},{"key":"3880_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers12082104","volume":"12","author":"M Al-Jundi","year":"2020","unstructured":"Al-Jundi M, Thakur S, Gubbi S, Klubo-Gwiezdzinska J (2020) Novel targeted therapies for metastatic thyroid cancer\u2014a comprehensive review. Cancers (Basel) 12:1\u201337. https:\/\/doi.org\/10.3390\/cancers12082104","journal-title":"Cancers (Basel)"},{"key":"3880_CR52","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1016\/j.bbamcr.2014.02.012","volume":"2263","author":"K Kondratska","year":"1843","unstructured":"Kondratska K, Kondratskyi A, Yassine M et al (1843) (2014) Orai1 and STIM1 mediate SOCE and contribute to apoptotic resistance of pancreatic adenocarcinoma. Biochim Biophys Acta Mol Cell Res 2263:2269. https:\/\/doi.org\/10.1016\/j.bbamcr.2014.02.012","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"3880_CR53","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/smll.200902355","volume":"6","author":"JM Rosenholm","year":"2010","unstructured":"Rosenholm JM, Peuhu E, Bate-Eya LT et al (2010) Cancer-cell-specific induction of apoptosis using mesoporous silica nanoparticles as drug-delivery vectors. Small 6:1234\u20131241. https:\/\/doi.org\/10.1002\/smll.200902355","journal-title":"Small"},{"key":"3880_CR54","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/s11095-009-0043-8","volume":"27","author":"H De Martimprey","year":"2010","unstructured":"De Martimprey H, Bertrand JR, Malvy C et al (2010) New core-shell nanoparticules for the intravenous delivery of sirna to experimental thyroid papillary carcinoma. Pharm Res 27:498\u2013509. https:\/\/doi.org\/10.1007\/s11095-009-0043-8","journal-title":"Pharm Res"},{"key":"3880_CR55","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.3892\/or.2017.5961","volume":"38","author":"Y Zhou","year":"2017","unstructured":"Zhou Y, Gu P, Li J et al (2017) Suppression of STIM1 inhibits the migration and invasion of human prostate cancer cells and is associated with PI3K\/Akt signaling inactivation. Oncol Rep 38:2629\u20132636. https:\/\/doi.org\/10.3892\/or.2017.5961","journal-title":"Oncol Rep"},{"key":"3880_CR56","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.3390\/cancers11091382","volume":"11","author":"M Aashiq","year":"2019","unstructured":"Aashiq M, Silverman DA, SNaara S et al (2019) Radioiodine-refractory thyroid cancer: molecular basis of redifferentiation therapies, management, and novel therapies. Cancers (Basel) 11:1382. https:\/\/doi.org\/10.3390\/cancers11091382","journal-title":"Cancers (Basel)"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-021-03880-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-021-03880-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-021-03880-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,5]],"date-time":"2023-11-05T01:11:09Z","timestamp":1699146669000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-021-03880-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,21]]},"references-count":56,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["3880"],"URL":"https:\/\/doi.org\/10.1007\/s00018-021-03880-0","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,21]]},"assertion":[{"value":"19 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures involving human samples were ethically approved by Auria Biobank (decision AB19-2988) and the Hospital District of Southwest Finland and Turku University Hospital (decision T12\/011\/20) under the guidelines of General terms of the transfer of biological samples and data of the Auria Biobank Act (688\/2012). The participants were informed that their participation was voluntary. The zebrafish, animal model use was approved by the ethical committee, Project Authorization Board of Regional State Agency for Southern Finland under licenses ESAVI\/9339\/04.10.07 \/2016 and ESAVI\/31414\/2020.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants\u2019 who donated samples included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}